For more information or confidential assistance
Call 800-306-3180

Side Effects of Yaz and Yasmin Lead to Lawsuits Against Manufacturer Bayer

Both pulmonary embolism and stroke are caused by blood clots. Blood clots have proven to be Yaz or Yasmin side effects. Yaz and Yasmin are birth control pills manufactured by Bayer. The blood clots have affected women who otherwise have no family history of blood clotting and were at low risk for developing such clots. Blood clots may be reported in the legs, arms, heart, lungs, or brain and may lead to stroke or pulmonary embolism.

Pulmonary embolism and stroke are side effects of Yaz and Yasmin

Pulmonary embolism is the medical term for blood clots that occur in the lungs. Symptoms of the potentially life-threatening condition may include anxiety, fever, bloody cough, and shortness of breath. Some people who experience the condition may require surgery to facilitate removal of the clot.

Yaz stroke may occur as the result of blood clots in the brain. A stroke may leave affected women unable to hear or see, unable to communicate with or comprehend others, and may cause the inability to move properly or control bladder and bowel functions. Such a stroke may require years of therapy and victims may never fully recover.

Bayer settles many cases involving blood clots with others pending

Judge David Herndon of the Southern District of Illinois issued a stay in order to grant the parties involved in the ongoing lawsuits time to negotiate a Yaz settlement. The Yaz bellwether trials are scheduled to begin next month, in September 2012. Thus far, the cases eligible for the multidistrict litigation (MDL) involve injuries stemming from blood clots, stroke, deep vein thrombosis, pulmonary embolism, and gallbladder disease for plaintiffs who had taken Yaz or Yasmin.

As of July 19, 2012, Bayer has settled at least 1,877 cases involving blood clots, paying out approximately $402.6 million. A Bayer stockholders’ newsletter released earlier this month indicated that 12,325 lawsuits have been filed against the company in regards to Yaz and Yasmin. Should the cases continue to be settled at the current per plaintiff average payout, Bayer may wind up paying more than $1.29 billion in settlements.

Patients who have experienced any of the side effects listed above should consult an attorney to see if they are eligible to join the thousands of others throughout the country who have filed litigation.

[SmartLink yazlawsuit]